Structured intelligence coverage

Structured records are temporarily unavailable. The published profile and its source ledger remain accessible.

Identity checks do not refresh the age of governance evidence. Open a record for its source date and review state.

Profile

Identity, professional record and current appointments.

Overview

Professional record at a glance

A concise summary of information supported by the cited public sources. Missing information is treated as unknown, not as a negative finding.

Current roles
22 current organizations shown on this profile
Board positions
22 supported by public sources, 0 supplied by the profile owner
Committee roles
4Roles supported by the sources cited on this profile
Qualifications
Not establishedNo qualification is currently confirmed by the cited sources

Professional narrative

About

President and CEO of Amgen since 2012 and Chairman since 2013. Previously served as Chief Operating Officer and Chief Financial Officer of Amgen. Former Managing Director at Morgan Stanley with responsibility for banking and corporate finance in Europe.

Sources are shown with the information they support.

Current roles

Appointments & responsibilities

Board appointments

Independent Director

Boeing (NYSE: BA-PA)

Jan 1, 2016 – Present

Independence: Independent

Source effective: 2026-03-06 · Observed: 2026-05-01T01:35:01.207+00:00

confirmedView source

Governance

Board appointments, committee responsibilities and disclosed relationships.

Committee appointments across companies · Temporarily unavailable

Structured records for this section are unavailable. This does not establish that no records exist. Published profile sources remain in Evidence & History.

Board and advisory record

Board service

Sources are shown with each role, education record, or credential.

Independent Director

Boeing

2016-01-01 · current

Confirmed by public sourceView source

Director

Amgen

Current · start date not disclosed

Confirmed by public sourceView source

Connections

Explore the roles, education and affiliations published in this record.

Amgen

Open Amgen profile →

Director at Amgen

Start not stated → End not stated

current · source reported

Observed: 2026-09-24

AmgenAmgenBoeingBoeingRobert A. Bradway

Dashed lines mark past roles. Select a connection to see its dates and sources.

Relationship map

Connected through the public record

Direct relationships from verified facts and published résumé records. Private connections are excluded.

  • Amgen

    Director

    Verified public fact

  • Boeing

    Independent Director

    Verified public fact

Direct public links only

Only published affiliations are shown here. Private relationships require authorized access.

Experience

Career history, education, credentials and public contributions.

Published record

Featured coverage

Selected publications and public sources used to establish this profile. Inclusion records provenance; it is not an endorsement.

Source 1 · Sec FilingAMGN DEF 14A director slateSupports AI and ML experience, Board role, Committee assignments, Executive company, Executive title, Cybersecurity experience, Technology background.Open sourceSource 2 · Sec FilingBoeing director board sourceSupports Board membership, Committee assignments, Director since, Board independence.Open sourceSource 3 · Sec FilingAMGN 10-K executive officersSupports AI and ML experience, Cybersecurity experience, Executive company, Executive title, Other Company Role, Technology background.Open sourceSource 4 · Sec FilingAmgen Inc. director board sourceSupports Board membership, Board independence.Open source

Basis

Identifiers, sources, dates and record limitations.

Identifiers

Alpha ID
alpha:person:robert-a-bradway
Record version
public-0

Published evidence records

10 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. AMGN DEF 14A director slate

    sec filing · Source published: Apr 7, 2026 · Retrieved: May 16, 2026

    Supports 7 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Board role: Board role: Chair · Claim reviewed: May 16, 2026
    • Committee assignments: Committee assignments: Equity Award, Executive · Claim reviewed: May 16, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Executive company: Executive at Amgen Inc. · Claim reviewed: May 16, 2026
    • Executive title: Executive title: President and Chief Executive Officer · Claim reviewed: May 16, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 16, 2026

  2. Boeing director board source

    sec filing · Source published: Mar 6, 2026 · Retrieved: May 3, 2026

    Supports 4 claims
    • Board independence: Independent director · Claim reviewed: May 3, 2026
    • Board membership: Serves on the board of Amgen Inc. · Claim reviewed: May 3, 2026
    • Board membership: Serves on the board of Boeing · Claim reviewed: May 3, 2026
    • Committee assignments: No committee assignment disclosed in the cited filing · Claim reviewed: May 3, 2026

  3. BA DEF 14A director slate

    sec filing · Source published: Mar 6, 2026 · Retrieved: May 1, 2026

    Supports 2 claims
    • Board role: Board role: Director · Claim reviewed: May 1, 2026
    • Committee assignments: Committee assignments: Compensation, Nominating/Governance · Claim reviewed: May 1, 2026

  4. Open source

    sec proxy · Source published: Mar 6, 2026 · Retrieved: May 1, 2026

    Supports 1 claim
    • Professional Role: Independent Director at Boeing · Claim reviewed: May 16, 2026

  5. AMGN 10-K executive officers

    sec filing · Source published: Feb 13, 2026 · Retrieved: May 4, 2026

    Supports 6 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Executive company: Executive at Amgen Inc. · Claim reviewed: May 16, 2026
    • Executive title: Executive title: Chairman of the Board, President and Chief Executive Officer · Claim reviewed: May 4, 2026
    • Other Company Role: Robert A. Bradway is also linked to The Boeing Company as Director. · Claim reviewed: May 4, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 16, 2026

  6. Amgen Inc. director board source

    sec filing · Source published: Apr 9, 2025 · Retrieved: May 3, 2026

    Supports 2 claims
    • Board independence: Not independent (executive director) · Claim reviewed: May 3, 2026
    • Board membership: Serves on the board of Amgen Inc. · Claim reviewed: May 3, 2026

  7. Open source

    sec filing · Source published: Apr 9, 2025 · Retrieved: May 3, 2026

    Supports 1 claim
    • Professional Role: Director at Amgen · Claim reviewed: May 16, 2026

  8. AMGN executive roster source

    sec filing · Source published: Date unavailable · Retrieved: May 3, 2026

    Supports 5 claims
    • AI expertise: AI expertise: not identified in the cited filing · Claim reviewed: May 3, 2026
    • AI governance relevance: AI governance relevance reported from role and filings · Claim reviewed: May 3, 2026
    • Executive company: Executive at Amgen Inc. · Claim reviewed: May 16, 2026
    • Executive function: Enterprise Leadership (CEO) · Claim reviewed: May 3, 2026
    • Executive title: Executive title: Chairman of the Board of Directors, President and Chief Executive Officer · Claim reviewed: May 3, 2026

  9. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of Boeing · Claim reviewed: May 3, 2026

  10. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of Amgen Inc. · Claim reviewed: May 3, 2026

Sources

Sources and published information

Each item links to the public source used to support it. When sources disagree, the item is clearly marked for review.

AI and ML experience · CorroboratedAI and ML experience: not identified in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 4, 2026

AI expertise · Source reportedAI expertise: not identified in the cited filing1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 3, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

AI governance relevance · Source reportedAI governance relevance reported from role and filings1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 3, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Board independence · Under reviewNot independent (executive director)1 source
Verification
Under review
Confidence
95%
Last reviewed
May 3, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Board independence · Under reviewIndependent director1 source
Verification
Under review
Confidence
95%
Last reviewed
May 3, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Board membership · CorroboratedServes on the board of Amgen Inc.Supported by 3 public records3 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
Board membership · CorroboratedServes on the board of BoeingSupported by 3 public records2 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
Board role · Source reportedBoard role: Chair1 source
Verification
Source reported
Confidence
92%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Board role · Source reportedBoard role: Director1 source
Verification
Source reported
Confidence
92%
Last reviewed
May 1, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 1, 2026

Committee assignments · Source reportedNo committee assignment disclosed in the cited filing1 source
Verification
Source reported
Confidence
95%
Last reviewed
May 3, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Committee assignments · Source reportedCommittee assignments: Compensation, Nominating/Governance1 source
Verification
Source reported
Confidence
88%
Last reviewed
May 1, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 1, 2026

Committee assignments · Source reportedCommittee assignments: Equity Award, Executive1 source
Verification
Source reported
Confidence
88%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Cybersecurity experience · CorroboratedCybersecurity experience: not identified in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 4, 2026

Executive company · CorroboratedExecutive at Amgen Inc.Supported by 3 public records3 sources
Verification
Corroborated
Confidence
94%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 4, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Executive function · Source reportedEnterprise Leadership (CEO)1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 3, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Executive title · Source reportedExecutive title: Chairman of the Board of Directors, President and Chief Executive Officer1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 3, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Executive title · Source reportedExecutive title: Chairman of the Board, President and Chief Executive Officer1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 4, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 4, 2026

Executive title · Source reportedExecutive title: President and Chief Executive Officer1 source
Verification
Source reported
Confidence
85%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Other Company Role · Source reportedRobert A. Bradway is also linked to The Boeing Company as Director.1 source
Verification
Source reported
Confidence
70%
Last reviewed
May 4, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 4, 2026

Technology background · CorroboratedTechnology background: not identified in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 4, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

View all sources10 records
  1. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

    Supports: AI and ML experience · Board role · Committee assignments · Executive company · Executive title · Cybersecurity experience · Technology background

  2. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

    Supports: Board membership · Committee assignments · Director since · Board independence

  3. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 1, 2026

    Supports: Board role · Committee assignments

  4. https://www.sec.gov/Archives/edgar/data/12927/000119312526096787/d39411ddef14a.htm

    Sec Proxy · Tier not stated · Reviewed May 1, 2026

    Supports: Independent Director at Boeing (NYSE: BA-PA)

  5. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 4, 2026

    Supports: AI and ML experience · Cybersecurity experience · Executive company · Executive title · Other Company Role · Technology background

  6. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

    Supports: Board membership · Board independence

  7. https://www.sec.gov/Archives/edgar/data/0000318154/000095017025052315/amgn-20250408.htm

    Sec Filing · Tier not stated · Reviewed May 3, 2026

    Supports: Director at Amgen (NASDAQ: AMGN)

  8. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

    Supports: AI expertise · AI governance relevance · Executive company · Executive function · Executive title

  9. https://www.sec.gov/Archives/edgar/data/12927/000119312526096787/d39411ddef14a.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership

  10. https://www.sec.gov/Archives/edgar/data/0000318154/000095017025052315/amgn-20250408.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership